Moderna Inc. (NASDAQ: MRNA) saw its stock plunge more than 14% on Thursday, following the company’s announcement of ...

Moderna uses the same mRNA technology in its highly safe and effective coronavirus vaccine. In the study, six macaques were vaccinated with the mRNA vaccine, and another six received an equivalent ...

Now, a new vaccine candidate from Moderna, mRNA-1769, has been shown to more effectively limit symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus ...

Today's actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX Inc. and Pfizer Inc. In early June, the FDA advised manufacturers of licensed and authorized COVID-19 vaccines ...

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Moderna Inc (Symbol: MRNA), where a total volume of 42,756 contracts has been ...

US stocks jumped on Thursday as investors weighed fresh inflation and labor data against high-running expectations for a ...

The combination candidate consists of Pfizer’s mRNA-based influenza vaccine candidate ... are the most efficient way to do this. Today’s results provide insight and direction towards achieving ...

Below is a chart showing LLY's trailing twelve month trading history, with the $950 strike highlighted in orange: Moderna Inc (Symbol: MRNA) options are showing a volume of 29,976 contracts thus ...

Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of ...

A recent study published in Cell shows that Moderna's experimental mRNA vaccine for mpox is more effective than existing vaccines at reducing symptoms and disease duration. Tested on macaques ...